Arginine is an epigenetic regulator targeting TEAD4 to modulate OXPHOS in prostate cancer cells
Alterations in metabolism and amino acid usage are common in cancer cells. Here, the authors show in prostate cancer cells that arginine globally upregulates nuclear-encoded oxidative phosphorylation genes by altering histone acetylation and retaining TEAD4 in the nucleus to transactivate genes.
Guardado en:
Autores principales: | Chia-Lin Chen, Sheng-Chieh Hsu, Tan-Ya Chung, Cheng-Ying Chu, Hung-Jung Wang, Pei-Wen Hsiao, Shauh-Der Yeh, David K. Ann, Yun Yen, Hsing-Jien Kung |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d64749011def4c1eae0aaa79e53f01e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation
por: Bernd Schöpf, et al.
Publicado: (2020) -
Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex
por: Hung Yi Kristal Kaan, et al.
Publicado: (2017) -
Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s disease
por: Chun Chen, et al.
Publicado: (2021) -
Pontin arginine methylation by CARM1 is crucial for epigenetic regulation of autophagy
por: Young Suk Yu, et al.
Publicado: (2020) -
TEAD4 is a novel independent predictor of prognosis in LGG patients with IDH mutation
por: Yuan Hai-Yan, et al.
Publicado: (2021)